ProHema-CB Transplant
FT1050-05
Phase 1 mab terminated
Quick answer
ProHema-CB Transplant for Metabolic Disorders is a Phase 1 program (mab) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Metabolic Disorders
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated